Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study (Q37502039)
Jump to navigation
Jump to search
scientific article published on 25 July 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study |
scientific article published on 25 July 2011 |
Statements
1 reference
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study (English)
1 reference
John C Araujo
1 reference
Paul Mathew
1 reference
Andrew J Armstrong
1 reference
Edward L Braud
1 reference
Edwin Posadas
1 reference
Mathew Lonberg
1 reference
Gary E Gallick
1 reference
GĂ©ralyn C Trudel
1 reference
Prashni Paliwal
1 reference
Shruti Agrawal
1 reference
Christopher J Logothetis
1 reference
25 July 2011
1 reference
1 reference
63-71
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference